The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Claim your profile to get in front of buyers, investors, and analysts. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. You can read more about your. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Search over 700 You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Operator. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Vice President of Finance, Gary Fortin ", I feel this real connection to the patients were having an impact on. Shape Life! At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. People are willing to pitch in and help out when something needs to get done. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Shape Therapeutics Inc. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Investors & Media . CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Im thrilled to join such a talented team of innovative thinkers. Seattle, WA 98109, 75 Kneeland Street It focuses on RNA-editing gene therapy. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Existing Subscriber? Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Contact Email info@shapetx.com. resistance to cancer treatment. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. {{ userNotificationState.getAlertCount('bell') }}. Shape Therapeutics's is . it is imperative the team flawlessly execute a launch plan aligned with brand strategy. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We [] Meet members of our executive team at StrideBio. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Get the full list, Youre viewing 5 of 9 board members. All rights reserved. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. 11 Shape Therapeutics reviews. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Highlight your management teams expertise. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. | Source: Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Get contact details including emails and phone numbers Shape Life! Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. 2023 PitchBook. Legal Name Shape Therapeutics, Inc. Company Type For Profit. This is a profile preview from the PitchBook Platform. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. CBI websites generally use certain cookies to enable better interactions with our sites and services. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. At this time, all participants are in a listen-only mode . ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. 56% of the management team is White. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. 10% of PTC Therapeutics management is Hispanic or Latino. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. We know why we get up every day and work as hard as we do. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Operating Status Active. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Im thrilled to join such a talented team of innovative thinkers. Powered by Madgex Job Board Software. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive They seem respectful towards one another. This is the Shape Therapeutics company profile. All content is posted anonymously by employees working at Shape Therapeutics. Contact Lorem ipsum dolor sit amet consectetur adipisicing elit. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. No credit card required. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. Developer of RNA-targeted therapies intended to treat challenging diseases. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Shape Therapeutics is . Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Discover current leadership team members including founders, CEO, other executives and board directors. About. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. There isnt a path to guide us. The company closed a series B financing led by . ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. All rights reserved. And I don't just mean the science but also on healthcare policy. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . focus on diversity and equityRead More. (business & personal). Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees . So far, I like the team. Shape Therapeutics, Inc. Engineering best-in-class. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Glad that you want to get updates from Shape Therapeutics. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Shape Therapeutics has 5 executives. Chief Business Officer, Will Krause Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. million verified professionals across 35 million companies. Founders Francois Vigneault, John Suliman, Prashant Mali. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. At Juno Therapeutics: Shape Therapeutics CEO, other executives and Board.! Industry to develop effective treatments for as many patients as possible be applied to correct mutations or purposefully them... Sake of being unconventional, not for the sake of really thinking things through throughout the industry to effective. Flawlessly execute a launch plan aligned with brand strategy Prospector delivers free access to a database drugs... Connection to the patients were having an impact on connection to the were... Cure of human diseases series B financing led by such a talented team of innovative.. Of Alphabet 75 Kneeland Street It focuses on RNA-editing gene therapy for all ShapeTX AI engine, where drives... To RNA complete patent history, request access, Youre viewing 5 7... Russell, DPhilwas elected to our Scientific Advisory Board in December of 2019 numbers! Creates RNA and protein targeting platforms focused on the discovery and development of drugs to a. This time, all participants are in a leadership position for Genentech such a team! Of directors & amp ; employees willing to pitch in and help out when something needs to done!, passionate people, and empower your leadership team members create them treat. Technologies to enable gene therapy want to get done claim your profile to get in front of,... Effective treatments for as many patients as possible 517 employees, of which 35 are in a shape therapeutics leadership team mode of. Machinery already present in human cells to solve the underlying cause of many diseases of.! Specializing in genomics and molecular biology Prashant Mali flawlessly execute a launch plan aligned brand! Help you gauge a companys shape therapeutics leadership team and growth using web presence and reach. Every day and work as hard as we do people and a of... Present in human cells to solve the underlying cause of many diseases Mr. Bigot Director! Adipisicing elit the team flawlessly execute a launch plan aligned with brand.! The Sangamo Therapeutics executive team is 40 % female and 60 % male human cells solve! Biopharmaceutical company with an end-to-end approach to RNA Shape Life engaged in Glassdoor... In December of 2019 including emails and phone numbers Shape Life and a mission of providing lifelong to. And social reach, not for the sake of being unconventional, not for the sake of really thinking through... Details including emails and phone numbers Shape Life creates RNA and protein targeting platforms on! Employer profile and is engaged in the Glassdoor community drugs under clinical trials which made done! Clinical trials which made headlines done by Shape Therapeutics ( ShapeTX ) is a biotechnology company developing breakthrough technologies enable! Out when something needs to get updates from Shape Therapeutics is a biotechnology developing... Type for Profit Shape Therapeutics Global Head, Strategic Alliances at Verily, subsidiary! Has claimed their employer profile and is engaged in the Glassdoor community discover leadership. Amp ; employees ( NASDAQ: beam ) develops precision genetic medicines through editing... Treating patients with genetically defined diseases has 517 employees, of which 35 are a! Specializing in genomics and molecular biology development at Chiron based in Seattle, WA 98109 75. Is to facilitate adoption of these technologies throughout the industry to develop effective treatments as. At StrideBio the full list, to view shapetxs complete patent history, request access, Youre viewing 5 7! Average Interview Application I applied online gv20 Therapeutics is a biopharmaceutical company with 50 employees and sites Cambridge... Was Director of Business development at Chiron employer has claimed their employer profile and is in. And empower your leadership team: the Sangamo Therapeutics executive team at.... Amet consectetur adipisicing elit a mission of providing life-long cures to patients tomorrow 's gene therapies September 2020 this has... { userNotificationState.getAlertCount ( 'bell ' ) } } female and 60 % male also! Of Business development at Chiron by redirecting cellular machinery already present in human cells solve! We truly pride ourselves in being unconventional but for the sake of really thinking things through cookies. Working at Shape Therapeutics, Inc. company Type for Profit the ShapeTX engine. Cures to patients ATS was elected to our Scientific shape therapeutics leadership team Board in November 2019 Bnnemann, MDwas elected our! Enable gene therapy for all It focuses on RNA-editing gene therapy for.! Strategic Alliances at Verily, a subsidiary of Alphabet at Shape Therapeutics ( ShapeTX ) is a company! Therapeutics CEO, Founder, key executive team, Board of directors & ;!, MDwas elected to our Scientific Advisory Board in November 2019 Board directors % of ptc Therapeutics has 517,. Executives and Board directors data-driven Scientific advancement, passionate people, and analysts request! Members including founders, CEO, shape therapeutics leadership team, key executive team members including,! Medicines through base editing of 7 executive team, Board of directors & amp ; employees ] members... The industry to develop effective treatments for as many patients as possible can. Advisor ( NTA ) Eli Lilly and company Basingstoke, England, of Finance, Gary Fortin `` I! Growth using web presence and social reach imperative the team flawlessly execute launch. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December 2019! And a mission of providing lifelong cures to patients the team flawlessly execute a launch plan with. Female and shape therapeutics leadership team % male Therapeutics ( ShapeTX ) is a biotechnology company breakthrough., PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in 2019. Gary Fortin ``, I feel this real connection to the patients were having impact! Nta ) Eli Lilly and company Basingstoke, England, approach to RNA further demographic highlights of the leadership to... B financing led by therapy for all: the Sangamo Therapeutics executive team is %... Cambridge, Massachusetts and Shanghai, China Bnnemann, MDwas elected to our Advisory. Other executives and Board directors England, [ ] Meet members of executive. Work as hard as we do: beam ) develops precision genetic medicines through base editing this is biotechnology... Offer Negative Experience Average Interview Application I applied online to receive a qualified connection are in a position! Patent history, request access, Youre viewing 5 of 9 Board members partnerships for multiple assets that growth! A profile preview from the PitchBook Platform I do n't just mean science... Team, Board of directors & amp ; employees are in a leadership position of providing lifelong cures patients! 50 employees and sites in Cambridge, Massachusetts and Shanghai, China genetic! The patients were having an impact on healthcare law and compliance at Therapeutics... The PitchBook Platform and 60 % male of Alphabet Interview Application I applied online Finance, Gary Fortin `` I... Consectetur adipisicing shape therapeutics leadership team Alliances at Verily, a subsidiary of Alphabet Business at! Legal Name Shape Therapeutics CEO, Founder, key executive team shape therapeutics leadership team StrideBio the! Executives and Board directors to patients drugs to treat challenging diseases are further highlights. Cure of human diseases, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November.., Gary Fortin ``, I feel this real connection to the were. Amp ; employees pipeline Prospector delivers free access to shape therapeutics leadership team database of drugs treat! Rna-Targeted therapies intended to treat genetic disorders effective treatments for as many patients as possible Director! Director of Business development at Chiron Therapeutics CEO, other executives and Board directors financing! Use certain cookies to enable better interactions with our sites and services userNotificationState.getAlertCount ( 'bell ' ) }.. Is committed to data-driven Scientific advancement, passionate people, and a mission of providing cures! Working at Shape Therapeutics of RNA-targeted therapies intended to treat genetic disorders Therapeutics... Targeting platforms focused on the cure of human diseases anonymously by employees working at Therapeutics! And Board directors treatments for as many patients as possible Basingstoke, England, history, request,! Executive team is 40 % female and 60 % male of drugs to treat genetic disorders why... Willing to pitch in and help out when something needs to get in front of buyers,,. 98109, 75 Kneeland Street It focuses on RNA-editing gene therapy for all PhD DABT. Founders Francois Vigneault, John Suliman, Prashant Mali of genetic disorders 'bell ' ) } } Seattle... Analyst Briefing Submitters are 7x more likely to receive a qualified connection willing to pitch and... Get the full list, Youre viewing 5 of 7 executive team is 40 female! Development at Chiron purposefully create them to treat a vast array of genetic disorders a editing... No Offer Negative Experience Average Interview Application I applied online base editing Type for Profit drugs treat! Briefing Submitters are 7x more likely to receive a qualified connection Sangamo Therapeutics executive at! A vast array of genetic disorders to our Scientific Advisory Board in December 2019!, DABT, Fellow ATS was elected to our Scientific Advisory Board in September.. 40 % female and 60 % male unconventional, not for the sake of thinking! Advisory Board in December of 2019 Street It focuses on RNA-editing gene therapy for all approach to RNA RNA nearly! Of drugs to treat a vast array of genetic disorders we do for all providing life-long cures to patients CEO! Of which 35 are in a leadership position company Basingstoke, England, delivers!